Mirum Pharmaceuticals, Inc. (MIRM)
82.93
-0.99
(-1.18%)
USD |
NASDAQ |
Oct 02, 16:00
81.77
-1.16
(-1.40%)
Pre-Market: 20:00
Mirum Pharmaceuticals Total Return Level : 82.93 for Oct. 2, 2026
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| October 02, 2026 | 82.93 |
| October 01, 2026 | 83.92 |
| September 30, 2026 | 85.48 |
| September 29, 2026 | 87.54 |
| September 28, 2026 | 87.96 |
| September 25, 2026 | 89.70 |
| September 24, 2026 | 89.36 |
| September 23, 2026 | 89.32 |
| September 22, 2026 | 91.39 |
| September 21, 2026 | 92.00 |
| September 18, 2026 | 91.83 |
| September 17, 2026 | 98.82 |
| September 16, 2026 | 97.37 |
| September 15, 2026 | 93.90 |
| September 14, 2026 | 96.75 |
| September 11, 2026 | 98.22 |
| September 10, 2026 | 100.61 |
| September 09, 2026 | 98.30 |
| September 08, 2026 | 99.53 |
| September 04, 2026 | 100.90 |
| September 03, 2026 | 100.63 |
| September 02, 2026 | 99.83 |
| September 01, 2026 | 98.34 |
| August 31, 2026 | 98.05 |
| August 28, 2026 | 97.46 |
| Date | Value |
|---|---|
| August 27, 2026 | 99.75 |
| August 26, 2026 | 98.51 |
| August 25, 2026 | 98.08 |
| August 24, 2026 | 96.72 |
| August 21, 2026 | 96.31 |
| August 20, 2026 | 97.07 |
| August 19, 2026 | 102.24 |
| August 18, 2026 | 100.87 |
| August 17, 2026 | 99.83 |
| August 14, 2026 | 100.64 |
| August 13, 2026 | 98.77 |
| August 12, 2026 | 98.97 |
| August 11, 2026 | 98.23 |
| August 10, 2026 | 98.70 |
| August 07, 2026 | 100.65 |
| August 06, 2026 | 94.12 |
| August 05, 2026 | 105.79 |
| August 04, 2026 | 104.33 |
| August 03, 2026 | 104.59 |
| July 31, 2026 | 105.95 |
| July 30, 2026 | 112.59 |
| July 29, 2026 | 107.57 |
| July 28, 2026 | 112.23 |
| July 27, 2026 | 114.20 |
| July 24, 2026 | 113.03 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Incyte Corp. | 115.30 |
| Insmed, Inc. | 111.12 |
| Galectin Therapeutics, Inc. | 3.90 |
| Kodiak Sciences, Inc. | 94.45 |
| Praxis Precision Medicines, Inc. | 295.51 |